Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLKB1 | P03952 | 10/20 | 0.48 |
| ▸ | KLHL20 | Q9Y2M5 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.45 |
| ▸ | ITGAV | P06756 | 1/20 | 0.45 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.45 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.45 |
| ▸ | LDLR | P01130 | 2/20 | 0.45 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.45 |
| ▸ | CIB1 | Q99828 | 1/20 | 0.45 |
| ▸ | GRB2 | P62993 | 1/20 | 0.44 |
| ▸ | FLT1 | P17948 | 1/20 | 0.43 |
| ▸ | F11 | P03951 | 1/20 | 0.43 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.43 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25457049 | 0.97 | KLKB1 (0.49) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25457071 | 0.95 | KLKB1 (0.48) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25456183 | 0.94 | KLKB1 (0.46) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25457101 | 0.92 | KLHL20 (0.47) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25455641 | 0.92 | KLKB1 (0.51) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25455166 | 0.92 | KLKB1 (0.51) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25455263 | 0.92 | KLKB1 (0.52) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25459090 | 0.90 | KLKB1 (0.59) | KLKB1ITGB3ITGB1ITGAVITGA5 | |
| SCHEMBL25455286 | 0.90 | KLKB1 (0.52) | KLKB1KLHL20ITGB3ITGB1ITGAV | |
| SCHEMBL25455193 | 0.89 | ITGB3 (0.52) | KLKB1KLHL20ITGB3ITGB1ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230145835-A1 | Modulators of Alpha-4-beta-7 Integrin and MAdCAM | QUANTUM INTELLIGENCE CORP. (KR) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230145835-A1 | Modulators of Alpha-4-beta-7 Integrin and MAdCAM | ITGB7, ITGAM, ITGA4 | KLKB1 1100/4885KLHL20 4508/4885ITGB3 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.